Home
About
FAQ
History (4)
Niemann-Pick Disease, Type B
Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis.
Pharmacoeconomic considerations in treating actinic keratosis.
Trends in the use of topical over the counter products in the management of dermatologic disease in the United States.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pharmacoeconomic considerations in treating actinic keratosis.
Neidecker MV, Davis-Ajami ML, Balkrishnan R, Feldman SR. Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics. 2009; 27(6):451-64.
View in:
PubMed
subject areas
Cost of Illness
Cost-Benefit Analysis
Economics, Pharmaceutical
Health Care Costs
Humans
Keratosis, Actinic
authors with profiles
Steven R. Feldman MD, PhD